Instil Bio, Inc. Diluted Shares Outstanding (Weighted Average)
Instil Bio, Inc. (TIL) reported Diluted Shares Outstanding (Weighted Average) of 6.78 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 6.78M shares, a 2.80% increase year-over-year.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.78M shares, a 3.82% increase year-over-year.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 6.78M shares, a 3.94% increase year-over-year.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 6.76M shares, a 3.86% increase year-over-year.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 6.67M shares, a 2.43% increase from fiscal 2024.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 6.51M shares, a 0.10% increase from fiscal 2023.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 6.50M shares, a 0.44% increase from fiscal 2022.
- Instil Bio, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 6.48M shares, a 93.89% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.78M shares 10-Q · filed 2026-08-13 | 6.78M shares 10-Q · filed 2026-08-13 | 6.78M shares derived: average of 3 quarters · filed 2026-08-13 | 6.78M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 6.78M shares 10-Q · filed 2026-05-15 | 6.78M shares derived: average of 2 quarters · filed 2026-05-15 | 6.77M shares derived: average of 3 quarters · filed 2026-05-15 | 6.73M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 6.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 6.77M shares derived: average of 2 quarters · filed 2026-03-27 | 6.71M shares derived: average of 3 quarters · filed 2026-08-13 | 6.67M shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 6.76M shares 10-Q · filed 2025-11-13 | 6.68M shares derived: average of 2 quarters · filed 2026-08-13 | 6.63M shares 10-Q · filed 2025-11-13 | 6.60M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 6.60M shares 10-Q · filed 2026-08-13 | 6.56M shares 10-Q · filed 2026-08-13 | 6.55M shares derived: average of 3 quarters · filed 2026-08-13 | 6.54M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 6.53M shares 10-Q · filed 2026-05-15 | 6.53M shares derived: average of 2 quarters · filed 2026-05-15 | 6.52M shares derived: average of 3 quarters · filed 2026-05-15 | 6.52M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 6.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 6.52M shares derived: average of 2 quarters · filed 2026-03-27 | 6.51M shares derived: average of 3 quarters · filed 2026-03-27 | 6.51M shares 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | 6.51M shares 10-Q · filed 2025-11-13 | 6.51M shares derived: average of 2 quarters · filed 2025-11-13 | 6.50M shares 10-Q · filed 2025-11-13 | 6.50M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 6.50M shares 10-Q · filed 2025-08-13 | 6.50M shares 10-Q · filed 2025-08-13 | 6.50M shares derived: average of 3 quarters · filed 2025-08-13 | 6.50M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 6.50M shares 10-Q · filed 2025-05-13 | 6.50M shares derived: average of 2 quarters · filed 2025-05-13 | 6.50M shares derived: average of 3 quarters · filed 2025-05-13 | 6.50M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 6.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 6.50M shares derived: average of 2 quarters · filed 2025-03-04 | 6.50M shares derived: average of 3 quarters · filed 2025-03-04 | 6.50M shares 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | 6.50M shares 10-Q · filed 2024-11-13 | 130.08M shares 10-Q · filed 2023-11-13 | 6.50M shares derived: average of 2 quarters · filed 2024-11-13 | 6.50M shares 10-Q · filed 2024-11-13 | 130.08M shares 10-Q · filed 2023-11-13 | -85.69M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 6.50M shares 10-Q · filed 2024-08-13 | 130.08M shares 10-Q · filed 2023-08-14 | 6.50M shares 10-Q · filed 2024-08-13 | 130.08M shares 10-Q · filed 2023-08-14 | -116.42M shares derived: average of 3 quarters · filed 2024-08-13 | -54.90M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 6.50M shares 10-Q · filed 2024-05-10 | 130.08M shares 10-Q · filed 2023-05-11 | -177.88M shares derived: average of 2 quarters · filed 2024-05-10 | -75.36M shares derived: average of 3 quarters · filed 2024-05-10 | -24.18M shares derived: average of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -362.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -116.30M shares derived: average of 2 quarters · filed 2024-03-21 | -34.41M shares derived: average of 3 quarters · filed 2024-03-21 | 6.48M shares 10-K · filed 2024-03-21 | 129.51M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 129.68M shares 10-Q · filed 2023-11-13 | 129.52M shares derived: average of 2 quarters · filed 2023-11-13 | 129.39M shares 10-Q · filed 2023-11-13 | 129.34M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 129.37M shares 10-Q · filed 2023-08-14 | 129.24M shares 10-Q · filed 2023-08-14 | 129.23M shares derived: average of 3 quarters · filed 2023-08-14 | 129.12M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 129.12M shares 10-Q · filed 2023-05-11 | 129.16M shares derived: average of 2 quarters · filed 2023-05-11 | 129.04M shares derived: average of 3 quarters · filed 2023-05-11 | 128.97M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 129.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 129.00M shares derived: average of 2 quarters · filed 2023-03-31 | 128.91M shares derived: average of 3 quarters · filed 2023-03-31 | 105.99M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 128.79M shares 10-Q · filed 2022-11-14 | 128.77M shares derived: average of 2 quarters · filed 2022-11-14 | 98.26M shares 10-Q · filed 2022-11-14 | 77.41M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 128.74M shares 10-Q · filed 2022-08-12 | 82.48M shares 10-Q · filed 2022-08-12 | 60.29M shares derived: average of 3 quarters · filed 2022-08-12 | 49.45M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | 34.98M shares 10-Q · filed 2022-05-16 | 26.06M shares derived: average of 2 quarters · filed 2022-05-16 | 23.02M shares derived: average of 3 quarters · filed 2022-05-16 | 21.47M shares derived: average of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | 17.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 17.04M shares derived: average of 2 quarters · filed 2022-03-07 | 16.97M shares derived: average of 3 quarters · filed 2022-03-07 | 16.00M shares 10-K · filed 2022-03-07 | ||||
| 2020-09-30 | 16.93M shares 10-Q · filed 2021-11-15 | 16.89M shares derived: average of 2 quarters · filed 2021-11-15 | 15.62M shares 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 16.85M shares 10-Q · filed 2021-08-12 | 14.94M shares 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 13.00M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |